What's New in Health and Life Sciences
News from the European Comission
EUROPA - Research and Innovation: Medical Sciences
EUROPA - Research What's New in Health and life sciences - Medical research. This RSS feed includes the most recent updates to the European Commission's Research and Innovation web site on Europa in the area of Health and life sciences - Medical research. The last (or, in some news readers, the first) item of this feed will take you to the Medical Research web site. For more RSS news feeds visit http://ec.europa.eu/research/index.cfm?pg=rss
For more RSS news feeds click the link above.
An EU-funded project investigated how pathogenic viruses, including influenza A, take control of the protein synthesis machinery in human cells. This has provided valuable new knowledge, which paves the way for new flu treatments.
EU-funded researchers have helped generate the most accurate map to date of dark matter, the mysterious substance that makes up 80 % of the universe. The innovative big-data technologies they used will have a significant impact on fields as diverse as astrophysics and biomedical imaging.
An EU-funded project has made a breakthrough in medical imaging. By developing a photon-counting detector for CT scanners, higher-resolution images with lower radiation doses can be produced for accurate non-invasive screening and diagnosis of diseases.
Putting a fresh spin on the proverb 'the enemy of my enemy is my friend', EU-funded researchers have developed and tested an innovative treatment for infections caused by antimicrobial-resistant bacteria, which have developed into a major public health threat. This new weapon is a cocktail of bacteria-killing viruses called 'phages'.
An EU-funded project is set to drive the commercial development of breakthrough laser-engineered products inspired by the unique skin and scale textures of animals and insects, potentially leading to entirely new applications across industry, energy and medicine.
In the field of pharmaceuticals, the term 'polymorphism' refers to the existence of a single substance in two or more crystalline forms. These different forms can vary widely in their efficacy, bioavailability and even toxicity. An EU-funded project is working to develop a method for directing polymorphism in pharmaceutical compounds, thus promising better drug treatments for patients everywhere.
EU-funded researchers have discovered an important new mechanism by which cells flag and repair damage to their DNA - an unexpected finding that could improve the treatment of diseases such as cancer.
An organic molecule composed of simple sugars could become a potent weapon in the fight against rising antibiotic resistance, according to EU-funded researchers who have developed a novel, targeted drug-delivery technique to treat deadly tuberculosis and other lethal pathogens.
EU-funded researchers are studying the molecular mechanisms behind endometriosis in the hope of finding new treatment options for the millions of women around the world who suffer from the chronic inflammatory disease.